BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

Product Information

Summaries of product characteristics The BNF reviews summaries of product characteristics (SPCs) of all new products as well as revised SPCs for existing products. Medicines in Dentistry Specialist Advisory Service Information on drug therapy relating to dental treatment. Instant access to essential medicines information As a community pharmacist, we know you strive to provide safe and effective patient care. Oral or enteral syringes should be clearly labelled ‘Oral’ or ‘Enteral’ in a large font size; it is the healthcare practitioner’s responsibility to label the syringe with this information if the manufacturer has not done so. Nurse Prescribers’ Advisory Group The Nurse Prescribers’ Advisory Group oversees the list of drugs approved for inclusion in the Nurse Prescribers’ Formulary; the group includes representatives from a range of nursing disciplines and stakeholder organisations.

The BNF is a joint publication of the British Medical Association and the Royal Pharmaceutical Society. Patients receiving medicines containing cariogenic sugars should be advised of appropriate dental hygiene measures to prevent caries. One of the most significant changes to the monograph structure is the increased granularity, with a move from around 9 sections to over 20 sections; sections are only included when relevant information has been identified. In the BNF, preparations follow immediately after the monograph for the drug that is their main ingredient.As these labels have now been applied at the level of the dose form, a full list of medicinal products with their relevant labels would be extensive. When a difference between the advice in the BNF and the source is noted, the new information is assessed for reliability (using tools based on SIGN methodology if appropriate) and relevance to UK clinical practice. Information on drugs is drawn from the manufacturers’ product literature, medical and pharmaceutical literature, UK health departments, regulatory authorities, and professional bodies. Information is provided on selected excipients in skin preparations, in vaccines, and on selected preservatives and excipients in eye drops and injections.

Evidence grading Evidence grading to reflect the strengths of recommendations will be applied as content goes through the revalidation process. Cordarone X ®): reminder of risks of treatment and need for patient monitoring and supervision [MHRA/CHM advice]. Darcy BSc, MSc, IP, MPSNI, MRPharmS Sue Faulding BPharm, MSc, FRPharmS Daniel Greenwood MPharm(Hons), PgCertMedEd, PgDip(ClinPharm), PhD Tracy Hall BSc, MSc, RN, DN, NIP, Dip N, Cert N, QN Lynn Haygarth BPharm, MEd, FFRPS, FRPharmS, FCMHP Simon Hurding MB, ChB, MRCGP Valerie Joynson BSc, PGCE, PGCert Sandeep Kapur BSc(Hons), MB BS, MRCGP(Dist) Mark P. Cautionary and advisory labels that pharmacists are recommended to add when dispensing are included in the medicinal forms section. After selecting and administering the most appropriate drug by the most appropriate route, patients should be monitored to ensure they are achieving the expected benefits from drug treatment without any unwanted sideeffects.Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions. How to use BNF Publications in print How to use the BNF This edition of the BNF continues to display the fundamental change to the structure of the content that was first shown in BNF 70. Specialised commissioning decisions NHS England develops specialised commissioning policies that define access to specialised services for particular groups of patients to ensure consistency in access to treatments nationwide. The use of capital ‘L’ in mL is a printing convention throughout the BNF; both ‘mL’ and ‘ml’ are recognised SI abbreviations). Information about the use of specific drugs during pregnancy and breast-feeding can be found in their drug monographs under Pregnancy, and Breast-feeding (e.

Chapters, containing drug monographs describing the uses, doses, safety issues and other considerations involved in the use of drugs; drug class monographs; and treatment summaries, covering guidance on the selection of drugs. Changes, provides a list of significant changes, dose changes, classification changes, new names, and new preparations that have been incorporated into the BNF, as well as a list of preparations that have been discontinued and removed from the BNF. Psychotropic Drug Directory supports the optimal and rational use of medicines, to improve the quality of life for people with mental health needs. Medicines containing  17 mmol sodium in the total daily dose are considered to have a high sodium content and this is highlighted for medicines intended to be taken regularly (repeated use for more than 2 days every week) or long-term (continuous daily use for more than 1 month). uk Patient Information Lines NHS Urgent Care Services 111 Poisons Information Services UK National Poisons Information Service (for healthcare professionals only) Tel: 0344 892 0111 www.

Evidence used to make a recommendation is assessed for validity using standardised methodology tools based on AGREE II or SIGN and then assigned a level of evidence. Drug monographs have also changed structurally: additional sections have been added, ensuring greater regularity around where information is located within the publication.